Skip to main content
Premium Trial:

Request an Annual Quote

Proteopure Bags $100K from PLSG for Protein Isolation Technology

NEW YORK, March 21 (GenomeWeb News) - Pittsburgh Life Sciences Greenhouse said today it has invested $100,000 in Proteopure, a spinout of Carnegie Mellon University.

 

Proteopure is developing 2DE preparation kits using spin columns to bind and isolate proteins. It is expected to be commercially available this year.

 

PLSG is a public/private partnership founded by the University of Pittsburgh, Carnegie Mellon, UPMC Health System, and the Commonwealth of Pennsylvania.

The Scan

Looking for Omicron

NPR reports that SARS-CoV-2 testing in the US has gotten better but also that some experts say more needs to be done to better track the Omicron variant.

Holmes Alleges Abuse

The Associated Press reports that Theranos' Elizabeth Holmes has testified at her wire fraud trial that her business and romantic partner abused her.

Bit More Diverse, But More to Do

While Black and Hispanic patients are more likely to participate in cancer clinical trials than previously, they are still underrepresented, according to US News & World Report.

PNAS Papers on Yeast Gene Silencing, Zika Virus Inhibition, Immunoglobulin Hypermutation

In PNAS this week: gene silencing in Saccharomyces cerevisiae, possible neuroprotective role for SHFL in a mouse model of Zika virus infection, and more.